Relay Therapeutics (RLAY): Bellevue Group AG added to its stake +1M shares

7.38M

Shares reported · +1M vs prior quarter

0.85%

Disclosed portfolio weight

$52.2M

Reported value

Holdings as of

Sep 30, 2024

Filed

Nov 14, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 27, 2024Insider · 4 peopleInsiders: 5 sales (~$57K)
2. Oct 28, 2024Insider · 4 peopleInsiders: 5 sales (~$77K)
3. Oct 29, 2024InsiderCFO sold ~$14K of RLAY shares in the open market

What came next

1. Dec 16, 2024InsiderCEO sold ~$500K of RLAY shares in the open market
2. Dec 27, 2024Insider · 4 peopleInsiders: 5 sales (~$27K)
3. Jan 2, 2025InsiderOfficer sold ~$133K of RLAY shares in the open market
4. Jan 3, 2025InsiderOfficer sold ~$138K of RLAY shares in the open market
5. Jan 6, 2025InsiderOfficer sold ~$74K of RLAY shares in the open market
6. Jan 21, 2025InsiderCEO sold ~$565K of RLAY shares in the open market
7. Jan 22, 2025InsiderCEO sold ~$600K of RLAY shares in the open market
8. Jan 23, 2025InsiderCEO sold ~$598K of RLAY shares in the open market
9. Jan 28, 2025Insider · 4 peopleInsiders: 5 sales (~$345K)
10. Jan 29, 2025Insider · 3 peopleInsiders: 3 sales (~$342K)
11. Jan 30, 2025Insider · 4 peopleInsiders: 4 sales (~$396K)
12. Feb 11, 2025InsiderCEO sold ~$540K of RLAY shares in the open market
13. Feb 13, 2025InsiderCEO sold ~$279K of RLAY shares in the open market

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Relay Therapeutics

For Relay Therapeutics, OQRO holds 8 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RLAY page.

How this filing works

• SEC Form 13F

Other disclosures at Relay Therapeutics

• SEC Form 4Oct 30, 2026
• SEC Form 4Oct 30, 2026
• SEC Form 4Oct 30, 2026
• SEC Form 4Oct 8, 2026
• SEC Form 4Oct 8, 2026
• SEC Form 4Oct 8, 2026

Everything OQRO holds on this company is on its RLAY page.